Ensemble, améliorons la qualité en santé

Transparency Committee Opinion

FORSTEO

Date 16 July 2008
Pharmaceutical
formulation

FORSTEO 20 µg/80 µl, solution for injection in pre-filled pen
Pack of 1 pre-filled 3 ml pen – CIP code: 362 216-2

ATC code
  1. H05AA02
Active ingredient

teriparatide

Laboratory / Manufacturer LILLY FRANCE SAS
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the new indication of treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk of fracture.

For more information

Contacts

Contact évaluation des médicaments